P20GM144269
Project Grant
Overview
Grant Description
Kansas Center for Metabolism and Obesity Research (KC-MORE) - Center Overall: Project Summary
This COBRE proposal seeks to establish the Kansas Center for Metabolism and Obesity Research (KC-MORE), which will unify investigators from multiple departments and research centers at the University of Kansas Medical Center. The focus of this center will be on research related to the pathology of obesity, metabolic dysfunction, and obesity-related diseases.
Obesity is a critical problem that is harming the health of people in Kansas as well as the entire U.S. New research-driven solutions and therapies are needed to prevent and treat obesity, investigate metabolic signatures that underlie obesity, and examine mechanisms by which obesity initiates chronic disease.
The KC-MORE will serve to merge these areas of focus by:
1. Creating a shared intellectual home for obesity-related researchers through a common educational and seminar program.
2. Providing funding and mentorship for early stage obesity-related investigators to establish independent research careers.
3. Establishing scientific cores to facilitate translational research of both early stage and established investigators.
4. Partnering with departments to jointly recruit new investigators to KUMC focused on themes of the KC-MORE.
This central role in leading and coordinating obesity research and incentivizing future resources and recruitment will allow KUMC to synergize efforts and form multi-disciplinary collaborations on obesity, metabolism, and obesity-induced disease research in ways that would not occur without COBRE funding.
The KC-MORE will be led by two multi-PIs, Drs. Steven Weinman and John Thyfault, and a renowned senior investigator, Dr. Joseph Donnelly, who will serve as chair of the steering committee and lead human energy balance research. These leaders have multi-disciplinary but complimentary expertise in basic, clinical, and translational research.
Phase 1 of the center will support the development of four research project leaders (RPLs) with studies on neural control of energy balance, clinical-based approaches to weight loss in rural communities, and basic mechanisms of obesity-related fatty liver disease and hypertension. KC-MORE will also administer a pilot awards program to develop additional KC-MORE researchers.
The KC-MORE will lead three new scientific cores that provide a foundation for translational research capabilities: the Metabolism (MET) Core, the Cells, Tissues, Bioanalysis and Bioinformatics (CTBB) Core, and the Human Energy Balance (HEB) Core. These cores will support infrastructure and methodologies for the research project leaders, the pilot award recipients, and a large pool of established obesity-related researchers on campus.
A critical goal of Phase 1 of the KC-MORE COBRE will be to help RPLs develop independent, R01-funded research programs. Overall, the establishment of the KC-MORE will serve to develop a translational and multi-disciplinary obesity research program that will have a significant future impact by reducing the burden of obesity-related disease conditions.
This COBRE proposal seeks to establish the Kansas Center for Metabolism and Obesity Research (KC-MORE), which will unify investigators from multiple departments and research centers at the University of Kansas Medical Center. The focus of this center will be on research related to the pathology of obesity, metabolic dysfunction, and obesity-related diseases.
Obesity is a critical problem that is harming the health of people in Kansas as well as the entire U.S. New research-driven solutions and therapies are needed to prevent and treat obesity, investigate metabolic signatures that underlie obesity, and examine mechanisms by which obesity initiates chronic disease.
The KC-MORE will serve to merge these areas of focus by:
1. Creating a shared intellectual home for obesity-related researchers through a common educational and seminar program.
2. Providing funding and mentorship for early stage obesity-related investigators to establish independent research careers.
3. Establishing scientific cores to facilitate translational research of both early stage and established investigators.
4. Partnering with departments to jointly recruit new investigators to KUMC focused on themes of the KC-MORE.
This central role in leading and coordinating obesity research and incentivizing future resources and recruitment will allow KUMC to synergize efforts and form multi-disciplinary collaborations on obesity, metabolism, and obesity-induced disease research in ways that would not occur without COBRE funding.
The KC-MORE will be led by two multi-PIs, Drs. Steven Weinman and John Thyfault, and a renowned senior investigator, Dr. Joseph Donnelly, who will serve as chair of the steering committee and lead human energy balance research. These leaders have multi-disciplinary but complimentary expertise in basic, clinical, and translational research.
Phase 1 of the center will support the development of four research project leaders (RPLs) with studies on neural control of energy balance, clinical-based approaches to weight loss in rural communities, and basic mechanisms of obesity-related fatty liver disease and hypertension. KC-MORE will also administer a pilot awards program to develop additional KC-MORE researchers.
The KC-MORE will lead three new scientific cores that provide a foundation for translational research capabilities: the Metabolism (MET) Core, the Cells, Tissues, Bioanalysis and Bioinformatics (CTBB) Core, and the Human Energy Balance (HEB) Core. These cores will support infrastructure and methodologies for the research project leaders, the pilot award recipients, and a large pool of established obesity-related researchers on campus.
A critical goal of Phase 1 of the KC-MORE COBRE will be to help RPLs develop independent, R01-funded research programs. Overall, the establishment of the KC-MORE will serve to develop a translational and multi-disciplinary obesity research program that will have a significant future impact by reducing the burden of obesity-related disease conditions.
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Kansas City,
Kansas
66160
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 291% from $2,615,402 to $10,233,525.
University Of Kansas Medical Center Research Institute was awarded
KC-MORE: Advancing Obesity Research & Treatment
Project Grant P20GM144269
worth $10,233,525
from the National Institute of General Medical Sciences in April 2022 with work to be completed primarily in Kansas City Kansas United States.
The grant
has a duration of 4 years 10 months and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional).
Status
(Ongoing)
Last Modified 6/20/25
Period of Performance
4/1/22
Start Date
2/28/27
End Date
Funding Split
$10.2M
Federal Obligation
$0.0
Non-Federal Obligation
$10.2M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for P20GM144269
Transaction History
Modifications to P20GM144269
Additional Detail
Award ID FAIN
P20GM144269
SAI Number
P20GM144269-2578850110
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
YXJGGNC5J269
Awardee CAGE
3Q5T1
Performance District
KS-03
Senators
Jerry Moran
Roger Marshall
Roger Marshall
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $4,985,950 | 94% |
| National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) | Health research and training | Grants, subsidies, and contributions (41.0) | $317,437 | 6% |
Modified: 6/20/25